Replies to post #11035 on Innovus Pharmaceuticals Inc. (fka INNV)

[Biotech Pharmer]

Damaj should have negotiated in holding off on first shipment until Jan. with allergy season winding down. He was probably forced into this by Hikma because they know he is over a barrel and their other customers' Q3 and especially Q4 sales are winding down. Perfect deal for them. Not so much for INNV. It's just common sense...we're talking about an allergy drug